- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- September 2024
- 427 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 144 Pages
Global
From €2842EUR$2,990USD£2,388GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 189 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- August 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- December 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2025
- 130 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 125 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 342 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- September 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- June 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP

The Bare Metal Stent (BMS) market is a subset of the larger stent market. BMS are medical devices used to treat narrowed or blocked arteries. They are made of stainless steel or cobalt chromium and are designed to be inserted into the artery to keep it open. BMS are used to treat a variety of conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. BMS are typically used in combination with other treatments, such as angioplasty or bypass surgery.
BMS are considered to be a cost-effective treatment option for many patients, as they are less expensive than other stent types. They are also less invasive than other treatments, making them a popular choice for many patients.
Some of the major companies in the BMS market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more